The Global Spinal Implants market was valued at $5.2 billion in 2021 and it is expected to reach $17.3 billion at the CAGR of 11.4% during the forecast period between 2022 and 2032.
The spinal implant market is focused on the advancements of spinal surgery technologies. Incidents of spinal-related issues are rising and these health issues are common among the geriatric population. People from other age groups are also suffered from spinal injuries such as bone fracture, spinal density, and other spinal disorders. Therefore, such incidents have challenged the spinal implants market to grow and expand their business in different regions. However, spinal implants manufacturing companies are providing clinical and other surgical technologies to various hospitals around the globe.
North America is expected to hold the maximum market share in spinal implants market over the forecast period.
Source: SAI Research
Spinal implants are some clinical instruments used for treatment to strengthen the spinal cord through an operation or surgery. Various spinal problems have been growing issues in present days and this is the major factor for the manufacturing industries to produce more advanced surgical instruments which can help in proper and easy treatment. Spinal surgery is mainly used to facilitate fusion and correct the spinal cord. Manufacturing companies such as DePuy Synthes, Zimmer Biomet, Stryker Corporation, Orthofix International produce spinal implants with steel and titanium that could be available in specific sizes according to the treatment of a particular patient. Based on the procedure, the global spinal implants market is segmented into configuration and material. However, the competitive landscape of the spinal implants market provides information by major competitors at present days.
The rise in the geriatric population in North America is the main factor that is accelerating the growth of the spinal implants market across the region. Nearly 45 million people are more than 60 years old in the U.S country. These elderly people tend to have spinal issues which required immediate treatment and surgeries. Therefore, the demand for spinal implants is expected to rise in the U.S market through the forecast period. The rising prevalence of spondylitis is expected to propel the demand for spinal implants market. In the U.S, three to four percent of individuals aged 20 to 30 years and more than 75% of the individuals above 40 years suffer especially from lumbar spondylitis.
Therefore, it negatively affects the economic and socio condition of the country.
The newer and safer technologies are providing long-term solutions to spine related issues which are also increasing in demand. The traditional spinal implant surgery and its growth rate of failure created a sense of fear among the people. For example, the conventional method of spinal surgeries had complications resulted in a high failure rate. Even the procedure of the conventional method was invasive. New surgical techniques are very effective and less invasive. This is why demands for new surgical methods are increasing in hospitals and nursing homes across the globe. With strong government support, APAC is also becoming one of the fastest-growing markets in spinal implants. In addition, China is dominating the spinal implants market in the Asia-Pacific region followed by Japan in the second position and India in the third position due to the growing geriatric population. Healthcare expenditure is growing in India and China as patient awareness level is increasing in the Asia-Pacific region.
The key players in the global spinal implants market are Teva Pharmaceutical Industries Ltd., Pfizer Inc., Zydus Cadila, Rising Pharmaceuticals Inc., NervGen, RespireRx Pharmaceuticals Inc., Johnson & Johnson, NuVasive, Medtronic, Zimmer Biotech Holdings, and others domestic and global companies. Manufacturing companies such as Medtronic Company and DePuy Synthes held a dominating position over the last few years in the global spinal implants market. By trying to sustain their leading position, the companies are still investing in new and innovative product launches, doing partnerships and agreements with other manufacturing companies.
In addition, these companies are also focusing on geographic expansion and development on low-cost instruments for under-developing countries. Therefore, American medical device and manufacturing companies such as DePuy Synthes, Stryker Corporation, Zimmer Biomet Holdings, and Abbott Laboratories remained unbeaten for the past few years. These companies are also going to provide initiative facilities such as pharmaceutical packing, making equipment for spinal cord injury cases to hold their leading position and stay ahead in the global spinal implants market.
Scope of the Report:
Report Coverage |
Details |
||
Base Year: |
2021 |
Market Size in 2021: |
US$ 5.2 Billion |
Historical Data for: |
2019, 2020 and 2021 |
Forecast Period: |
2022 to 2032 |
Forecast Period 2022 to 2032 CAGR: |
11.4% |
2032 Value Projection: |
US$ 17.3 Billion |
Segments covered: |
By Product Type: Thoracic Fusion & Lumbar Fusion Devices, Cervical Fusion Devices, Spine Biologics, Vertebral Compression Fracture Treatment Devices, Spinal Decompression Devices, Non-Fusion Devices, Spine Bone Stimulators By Technology: Spinal Fusion & Fixation, Vertebral Compression Fracture Treatment, Spinal Decompression, Motion Preservation By Type: Open, Minimal Invasive Surgery By Material: Stainless Steel (SS), Titanium, Cobalt Chrome, Nitinol (A Nickel Titanium Alloy), Tantalum, Polyetheretherketone (PEEK) By End-User: Multi-specialty Hospitals, Ambulatory surgical centers, Clinics, Others |
||
Geographies covered: |
North America: U.S., Canada, Mexico Europe: Germany, U.K., Spain, France, Italy, Russia, Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Africa: South Africa, North Africa, and Africa Middle East: GCC, Israel, and Rest of Middle East Latin America: Brazil, Argentina, Rest of Latin America |
||
Companies covered: |
Teva Pharmaceutical Industries Ltd., Pfizer Inc., Zydus Cadila, Rising Pharmaceuticals Inc., NervGen, RespireRx Pharmaceuticals Inc., Johnson & Johnson, NuVasive, Medtronic, Zimmer Biotech Holdings, and others |
Global Spinal Implants Market Has Been Segmented Into:
Global Spinal Implant Market - By Product Type:
Global Spinal Implant Market – By Technology:
Global Spinal Implant Market - By Type:
Global Spinal Implant Market - By Material:
Global Spinal Implant Market - By End-User:
Global Spinal Implant Market – By Geography
Customization options available to meet your custom research requirements :